In vivo studies on myocardial ischemia-reperfusion injury rat model show an increase of myocardial metalloprotease expression and leucocyte recruitment in the control group while the administration of LOX-1 antibody led to a reduction of these effects and of the myocardial infarct area size [195,196]. The gene discussed is OLR1; the disease is myocardial infarction.